SES Launches New Content Orchestration and Hybrid Delivery Platform
11.9.2026 07:30:00 CEST | Business Wire | Press Release
SES today announced the launch of SES CORE, the first-of-its-kind content orchestration and hybrid delivery platform, designed to enable broadcasters and media customers to manage, monitor, and enable transmission of content seamlessly via satellite, fiber, and IP.
Built on infrastructure-neutral architecture, SES CORE provides a single user interface for content delivery. By bringing multiple distribution technologies into a unified orchestration layer, the platform enables customers to select the most effective content delivery path, guaranteeing service reliability and consistent delivery of high-quality content to global partners.
Through SES CORE, customers gain real-time visibility into service status by monitoring active content feeds. The platform provides network performance insights, automates operational tasks, and offers redundancy options. Together, those capabilities help broadcasters to manage content distribution more independently and efficiently, simplify operations and support business continuity.
Broadcasters and media companies looking to launch new channels, expand into additional regions and adopt new distribution models benefit from SES CORE’s ability to adapt to evolving business needs. This flexibility helps customers accelerate time to market, scale services more efficiently and unlock new opportunities for audience growth and revenue generation.
"Broadcasters and media companies are navigating increasingly complex distribution environments, where content needs to move seamlessly across multiple networks, technologies, and destinations," said Deepak Mathur, President of Media at SES. "As hybrid workflows become the norm, customers are looking for simpler ways to manage that complexity while maintaining the visibility and reliability they depend on. SES CORE addresses this evolution, providing a unified platform designed for the future of content orchestration and hybrid delivery."
Follow us on:
LinkedIn | Facebook | YouTube | X | Instagram
Read our Blogs >
Visit the Media Gallery >
About SES
At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where they are. With integrated multi-orbit satellites and our global terrestrial network, we deliver resilient, seamless connectivity and the highest quality video content to those shaping what’s next. Following our Intelsat acquisition, we now offer more than 100 years of combined global industry leadership—backed by a track record of bringing innovation “firsts” to market. As a trusted partner to customers and the global space ecosystem, SES is driving impact that goes far beyond coverage. The company is headquartered in Luxembourg and listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com
Forward-looking Statements
This press release contains certain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as “enables,” provides,” “gain,” and “guaranteeing.”
Forward-looking statements are not assurances of future performance and are subject to inherent uncertainties and risks that are difficult to predict. Factors that might cause such a difference include those discussed in our filings with the US Securities and Exchange Commission, including our Form 20-F, such as risks that changes in technology or the satellite communications industry could make our systems or services obsolete or subject to lower or reduced demand, and new technologies, products, or services may not be successful or achieve the anticipated benefits; a disruption or failure of our information systems, satellite control, and operations networks or other technology may disrupt our business. The forward-looking statements included in this press release are made only as of the date hereof and we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260910825607/en/
Contacts
For further information please contact:
SES Communications
SES.Press@ses.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incode launches TrustGraph, the first trust network built for the agentic era14.10.2026 15:00:00 CEST | Press Release
Incode Technologies, the global leader in AI-powered identity verification and fraud prevention, today launched TrustGraph, the privacy-preserving trust network that enables institutions to detect repeat fraud and agentic fraud, as well as to recognize legitimate customers with signals from across the network, without pooling, exchanging or exposing customer data. In Incode's early access program, institutions using TrustGraph detected up to 53% more fraud than with their existing models alone. TrustGraph runs on patented peer-to-peer cryptographic technology that connects fraud and trust signals across participating institutions without creating a central pool of customer records. It is the product of more than a decade of research conducted by Incode and Identiq, a pioneer in cryptographic peer-to-peer identity validation founded by security, privacy and identity veterans. Identiq was acquired by Incode in June 2026. Why now Fraudsters can now use AI agents to build synthetic identit
Lenovo Earns Multiple Leader Positions and Rising Star Designation in 2026 Future of Work Evaluations by Information Services Group14.10.2026 15:00:00 CEST | Press Release
As AI reshapes the digital workplace, enterprises are under growing pressure to improve employee productivity while reducing the complexity of IT operations and controlling costs. Independent research by Information Services Group (ISG) shows that organizations are addressing these demands with Lenovo Digital Workplace Solutions (DWS), applying one integrated approach to transform how IT teams manage everything from devices and lifecycle services to enabling more automated, AI-powered support experiences. With DWS, organizations around the world are moving beyond fragmented, reactive support models, helping prevent or resolve issues earlier to reduce employee disruption, and simplifying operations that can scale as business needs grow. This approach to delivering measurable outcomes for enterprise customers was recognized by ISG, a leading global technology research and advisory firm, earning Lenovo multiple Leader positions and a Rising Star designation in the 2026 ISG Provider Lens®
Debiopharm’s Pre-Clinical Proof-Of-Concept Research Unveils the Potential of Novel MultiLINK Linker Technology to Overcome Tumor Resistance14.10.2026 14:00:00 CEST | Press Release
Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standards of care to cure cancer and infectious diseases, today announced their latest research on antibody drug conjugate (ADC) research released at World ADC San Diego 2026. Results highlighted the pre-clinical performance of a selection of linker technology from Debiopharm’s MultiLINK™ Linker Technology suite (MLINK Select, MLINK Duo and MLINK HiSol), revealing positive implications for the development of next generation ADCs and for the future of cancer patients that require more innovative therapies to overcome their disease. Despite remarkable progress in the ADC field, many cancers remain difficult to treat due to biological complexities that challenge current-generation therapies. Tumor heterogeneity can enable cancer cells with low or absent target expression to escape treatment, while acquired resistance to single-payload ADCs may emerge over time and compr
Responsible AI for Children: IEEE Delivers a Trusted Safety Formula to Help Protect Kids Online14.10.2026 14:00:00 CEST | Press Release
The IEEE Standards Association, the global, consensus-building standards development organization of IEEE – the world’s largest technical professional organization and public charity dedicated to advancing technology for the benefit of humanity – today advanced its Responsible AI for Children (RAIC) Certification Program with the first product certified for children’s online safety. As children increasingly engage with digital and AI-enabled technologies, parents, educators, developers, and regulators want tools they can trust. IEEE’s Responsible AI for Children (RAIC) certification directly addresses these needs by translating global technical standards into a practical assessment for age-appropriate design and child safety – helping organizations prioritize children’s values, rights and well-being in their digital products and services. “As AI becomes part of children’s everyday lives, our responsibility as technology leaders has never been greater,” said Mary Ellen Randall, 2026 IEE
Takeda Presents Phase 2/3 IgGNITE Study Results of Investigational Subcutaneous TAK-881 in Primary Immunodeficiency Disease (PID) at ESID 202614.10.2026 14:00:00 CEST | Press Release
Takeda (TSE:4502/NYSE:TAK) announced detailed results from the pivotal Phase 2/3 IgGNITE clinical trial (TAK-881-3001) evaluating investigational TAK-881 [Immune Globulin Subcutaneous (Human), 20% Solution (SCIG 20%) and Recombinant Human Hyaluronidase], which, if approved, has the potential to become the first facilitated SCIG 20% therapy for patients with Primary Immunodeficiency Disease (PID) administered up to once-monthly (every 3 to 4 weeks). Data in participants aged 16 years and older are featured in two late-breaking posters at the 22nd Biennial Meeting of the European Society for Immunodeficiencies (ESID 2026) in Maastricht, the Netherlands. Previously shared topline results showed the clinical trial met its primary endpoint, demonstrating pharmacokinetic (PK) comparability between TAK-881 and HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase]. Secondary analyses showed TAK-881 demonstrated infection outcomes and safety and tolerability profil
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom